ATLANTA, Sept. 18, 2018 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading cardiac and vascular surgery company
focused on aortic disease, announced today that it will participate
in the upcoming Deutsche Bank 26th Annual Leveraged
Finance Conference on Tuesday, October 2,
2018 at The Phoenician in Scottsdale, AZ.
A live webcast of the Company's presentation is scheduled to
begin at 2:15 p.m. MST and will
feature an overview of the company by Pat
Mackin, Chairman, President and Chief Executive
Officer.
The live webcast can be accessed through CryoLife's website,
www.cryolife.com, on the Investor Relations page. An archived
copy of the webcast will be available for 90 days on the same
website.
About CryoLife, Inc.
Headquartered in suburban Atlanta,
Georgia, CryoLife is a leader in the manufacturing,
processing, and distribution of medical devices and implantable
tissues used in cardiac and vascular surgical procedures focused on
aortic repair. CryoLife markets and sells products in more
than 90 countries worldwide. For additional information about
CryoLife, visit our website, www.cryolife.com.
|
Contacts:
|
|
|
|
|
|
|
CryoLife
|
|
Gilmartin Group
LLC
|
|
D. Ashley
Lee
|
|
Greg Chodaczek / Lynn
Lewis
|
|
Executive Vice
President, Chief Financial Officer
and Chief Operating Officer
|
|
Phone:
646-924-1769
investors@cryolife.com
|
|
Phone:
770-419-3355
|
|
|
View original
content:http://www.prnewswire.com/news-releases/cryolife-to-present-at-deutsche-bank-26th-annual-leveraged-finance-conference-300714475.html
SOURCE CryoLife, Inc.